I had a great time doing an exclusive interview for AME Info, one of the leading news resources in the Middle East
It's not enough that Sergey Young wants us to live up to 30 years longer, but also immediately healthier. Be part of his 1 billion target and get a new lease on life
- Young manages pro bono projects, such as “Longevity@Work”, a corporate program designed for companies who want to invest in health and anti-aging practices for their employees
- In the future, we will be able to replace dysfunctional organs inside our bodies, too, and expand our lifespans simply by “printing” them
- Tech giants are becoming the biggest healthcare companies of the future
“I have bad news for you. You’re at high risk for heart disease if you don’t take action. Your cholesterol levels are way too high and that makes you a candidate for bigger health issues down the road.”
If that wasn’t bad enough news, some five years ago, when Sergey Young, founder of the $100 million Longevity Vision Fund (LVF), heard the results of his blood test results, his doctor dropped another bomb.
“Waiting seven years to do a blood test is a bad idea,” the doctor began, as he pulled the pin from his medical news grenade.
“I will prescribe you drugs and statins (lipid-lowering medication for patients at a high risk of cardiovascular disease) and that should lower your risk of heart problems, but you will need to take them every day for the rest of your life.”
And so, the story begins for Sergey Young’s longevity venture, a fund that backs organizations working on technology to reverse the aging process and prolong healthy human life.
“I can beat it!”
“I was ready to take medications for one, two, perhaps three months, but not till death do us part,” Sergey told AMEinfo in a recent exclusive interview.
“One of my three degrees is in Chemical Engineering, so naturally I don’t like putting chemicals into my body,” he added, not short on humor.
His second degree is in Economics. Not surprisingly, Young found out that statins were the 2nd largest revenue stream for pharmaceutical companies.
“It’s a guaranteed source of revenue for Big Pharma because these medications are prescribed for indefinite time periods… for life,” says Young.
No wonder that the revenue of pharmaceutical companies is on the rise. In fact, according to a report from IQVIA Institute for Human Data Sciences, the global market reached $1.2 trillion in 2018, a $100 billion increase from the year prior.
Taking matters in his own hands, Young signed a medical release form rejecting his doctor’s advice and went on to treat himself naturally by making certain changes in his daily lifestyle.
Three months after the adoption of a rigorous exercise routine, a steady diet abundant in fiber, supplements, and fish over red meat, Young’s cholesterol levels dropped by 25%. His lifestyle changes were as effective as taking statins.
